Novavax
NVAX
#5392
Rank
$1.53 B
Marketcap
$9.30
Share price
-2.05%
Change (1 day)
43.37%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of March 2026 : $0.29 Billion USD

According to Novavax's latest financial reports the company's total debt is $0.29 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2026)

Total debt by year

Year Total debt Change
2025-12-31$0.24 B7.98%
2024-12-31$0.23 B0.58%
2023-12-31$0.22 B-58.33%
2022-12-31$0.54 B21.1%
2021-12-31$0.45 B-2.99%
2020-12-31$0.46 B45.39%
2019-12-31$0.32 B0.84%
2018-12-31$0.31 B0.45%
2017-12-31$0.31 B0.45%
2016-12-31$0.31 B79985.82%
2015-12-31$0.39 M-60.42%
2014-12-31$0.99 M-46.94%
2013-12-31$1.88 M56.1%
2012-12-31$1.2 M276.56%
2011-12-31$0.32 M-20%
2010-12-31$0.4 M-17.7%
2009-12-31$0.48 M-97.88%
2008-12-31$22.9 M0.7%
2007-12-31$22.74 M-1.9%
2006-12-31$23.18 M-24.05%
2005-12-31$30.53 M-17.85%
2004-12-31$37.16 M-11.86%
2003-12-31$42.16 M1.84%
2002-12-31$41.4 M20.58%
2001-12-31$34.33 M71.69%
2000-12-31$20 M19900%
1999-12-31$0.1 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
$46.99 B 15,828.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$63.73 B 21,499.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$33.91 B 11,395.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$25.23 B 8,453.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
$1.03 B 251.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$1.9 M-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
$45.77 M-84.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
$1.5 M-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
$0.81 B 177.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$0.66 B 124.74%๐Ÿ‡บ๐Ÿ‡ธ USA